.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Moodys
Chubb
QuintilesIMS
Teva
Daiichi Sankyo
Deloitte
Johnson and Johnson
McKinsey
Cantor Fitzgerald
Baxter

Generated: January 22, 2018

DrugPatentWatch Database Preview

US Patents With Foreign Priority to United Kingdom Patent: 9707934

« Back to Dashboard


Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use
Depomed IncLAZANDAfentanyl citrateSPRAY, METERED;NASAL022569-001Jun 30, 2011RXYesNo➤ Subscribe➤ SubscribeYMANAGEMENT OF BREAKTHROUGH PAIN IN CANCER PATIENTS 18 YEARS OF AGE AND OLDER WHO ARE RECEIVING AND TOLERANT TO OPIOID THERAPY FOR THEIR UNDERLYING PERSISTENT CANCER PAIN
Depomed IncLAZANDAfentanyl citrateSPRAY, METERED;NASAL022569-002Jun 30, 2011RXYesYes➤ Subscribe➤ SubscribeYMANAGEMENT OF BREAKTHROUGH PAIN IN CANCER PATIENTS 18 YEARS OF AGE AND OLDER WHO ARE RECEIVING AND TOLERANT TO OPIOID THERAPY FOR THEIR UNDERLYING PERSISTENT CANCER PAIN
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Table 'thinkbio_newdpw.patent_gazette' doesn't exist